NCT05042115

Brief Summary

INTRODUCTION: Chronic low back pain (CLBD) is one of the major public health problems in the world. Given the complexity of the situation, complementary and alternative practices such as pain neuroscience education (PNE), clinical hypnosis (HC) and osteopathic manipulative treatment (OMT) are options for we manage these patients. OBJECTIVE: The aim of this study will be to evaluate the effects of OMT associated with PNE through HC on pain and disability in patients with CLBP compared to PNE and HC. MATERIALS AND METHODS: The study design will be a randomized clinical trial and 40 adults diagnosed with chronic low back pain will be recruited. Subjects will be randomized in two groups: the first group (G1) will be submitted to the PNE based on information from the book "Explain Pain" with hypnotic suggestions. Group 2 (G2) will receive PNE following the book "Explain Pain" with hypnotic suggestions associated with OMT. Volunteers will be evaluated by a blind researcher the interventions performed in the allocation of groups. The evaluation moments will be pre-intervention and immediately after the end of the last intervention for G1 and G2. Volunteers continued to be evaluated 4 weeks after completion of the protocols. Pain will be evaluated as the main outcome, being evaluated by the numerical pain scale. Pain will also be assessed by the pressure threshold using a pressure algometer device (Fnd-50, PIAB 50-n, Italy) in the lumbar region. Still as the main outcome, disability will be assessed using the Oswestry Disability Questionnaire. As secondary outcomes, the patient's global impression of improvement, central sensitization, biopsychosocial factors will be evaluated. The patient's global impression of improvement will be assessed using the Percentage of Improvement Scale with a score of -5 to +5; the Central Sensitization will be assessed using the Central Sensitization Questionnaire and the biopsychosocial factors using the Start Beck Toll questionnaire. In addition, the behavior of the autonomic nervous system will be evaluated through the Heart Rate Variability (HRV), which will be analyzed through linear methods, in the domains of time and frequency, and by geometric indices. The researcher/evaluator will be blinded to the allocation of intervention groups. Given the nature of the study, it is impossible to blind the researcher/therapist and volunteers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable low-back-pain

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 13, 2021

Completed
12 months until next milestone

Study Start

First participant enrolled

September 10, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2023

Completed
Last Updated

March 13, 2024

Status Verified

March 1, 2024

Enrollment Period

3 months

First QC Date

September 4, 2021

Last Update Submit

March 12, 2024

Conditions

Keywords

Low Back Pain

Outcome Measures

Primary Outcomes (3)

  • Pain perception

    The Pain suffered in the last week will be assessed by the Numerical pain scale, with a range of 0 - 10

    T0= before the protocol; T1= until 24 hours after the end protocol; T2= four weeks after end protocols

  • Pain pressure threshold

    Pain will be assessed by the pressure threshold using a pressure algometer device in the lumbar region. The assessment will be conducted specifically in the paravertebral muscles bilaterally at levels L1 to L5.

    T0= before the protocol; T1= until 24 hours after the end protocol; T2= four weeks after end protocols

  • Disability

    Disability will be assessed using the Oswestry Disability Questionnaire

    T0= before the protocol; T1= until 24 hours after the end protocol; T2= four weeks after end protocols

Secondary Outcomes (3)

  • Patient's global impression of improvement

    T0= before the protocol; T1= until 24 hours after the end protocol; T2= four weeks after end protocols

  • Central Sensitization and biopsychosocial factors

    T0= before the protocol; T1= until 24 hours after the end protocol; T2= four weeks after end protocols

  • Heart Rate Variability

    T0= before the protocol; T1= until 24 hours after the end protocol; T2= four weeks after end protocols

Study Arms (2)

Education in pain neurosciences and clinical hypnosis

EXPERIMENTAL

Pain neuroscience education and clinical hypnosis

Other: Education in pain neurosciences and clinical hypnosis

Education in pain neurosciences and clinical hypnosis plus Osteopathic manipulative treatment

ACTIVE COMPARATOR

Pain neuroscience education and clinical hypnosis, associated with osteopathic manipulative treatment

Other: Education in pain neurosciences and clinical hypnosis plus osteopathic manipulative treatment

Interventions

Will be performed education in pain neurosciences and clinical hypnosis, in 4 sessions during 4 weeks

Education in pain neurosciences and clinical hypnosis

Will be performed education in pain neurosciences and clinical hypnosis, and only for this group will be delivered osteopathic manipulative treatment, in 4 sessions during 4 weeks

Education in pain neurosciences and clinical hypnosis plus Osteopathic manipulative treatment

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Nonspecific Low Back Pain for at least 3 months
  • Score on the numerical pain scale of at least 3 points

You may not qualify if:

  • Data from participants with less than 95% of sinus beats
  • Participants that present increased symptoms in any stages of the study
  • Patients who are undergoing concomitant physical therapy treatment, patients with contraindications to exercise, smokers/alcoholics, severe vertebral or neural pathologies, previous spine surgeries, cardiorespiratory disease, LBP as a secondary complaint, pregnancy, hearing problems, or illiteracy patients, not will are able to participate the protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anne Kastelianne

Presidente Prudente, São Paulo, Brazil

Location

Related Publications (1)

  • Luchesi GLS, da Silva AKF, Amaral OHB, de Paula VCG, Jassi FJ. Effects of osteopathic manipulative treatment associated with pain education and clinical hypnosis in individuals with chronic low back pain: study protocol for a randomized sham-controlled clinical trial. Trials. 2022 Dec 30;23(1):1066. doi: 10.1186/s13063-022-07040-y.

MeSH Terms

Conditions

Low Back Pain

Interventions

Educational StatusHypnosisManipulation, Osteopathic

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation CharacteristicsMind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and ActivitiesMusculoskeletal ManipulationsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
A simple randomized sequence will be created through the website www.randomization.com by a collaborator external to the researchers directly involved in the research. After the initial assessment, the researcher will access the randomization envelope and the participant will be allocated to 1 of the 2 treatment groups. The allocation will be hidden using opaque envelopes, sealed, and identified by number. The researcher/evaluator will be blinded to the allocation of intervention groups. Given the nature of the study, it is impossible to blind the researcher/therapist and volunteers
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Education in Pain Neuroscience through Clinical Hypnosis associated with Osteopathic Manipulative Treatment
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2021

First Posted

September 13, 2021

Study Start

September 10, 2022

Primary Completion

November 30, 2022

Study Completion

February 28, 2023

Last Updated

March 13, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

The IPD will be shared by request

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
After one year from publication
Access Criteria
The request must be sent to the email address provided in the registration

Locations